The PhRMA Foundation today announced the appointment to its Board of Directors of Aida Habtezion, MD, Chief Medical Officer at Pfizer, Maha Radhakrishnan, MD, Chief Medical Officer at Biogen, George Addona, PhD, Senior Vice President and Head of Discovery, Preclinical and Translational Medicine at Merck Research Laboratories, and Lori Reilly, Esq, Chief Operating Officer at PhRMA.
Hear advice from a former PhRMA Foundation Scientific Advisory Committee member on applying for research grants from the Foundation. Peter J. Neumann, ScD, director of the Center for the Evaluation of Value and Risk in Health at Tufts Medical Center, shared his insight in a recent webinar.
Research by Foundation-funded scientists helps demonstrate why policymakers should consider the role of patient values and circumstances in how best to reduce disparities in vaccination.
Communicating research to the public benefits both researchers and society, but many scientists do not have adequate opportunities to receive science communications training. In this blog, learn 5 tips for writing a lay summary, a research description that uses clear, plain language for a public audience.
Value Assessment Initiative
The PhRMA Foundation’s Value Assessment Initiative promotes the development of advanced value-assessment so decision makers have better tools to assess high- and low-value care in the U.S. health system. The initiative funds new research and innovative efforts to assess the value of medicines and health care services, improve patient outcomes and reduce inefficiency. Learn more.
Centers of Excellence in Value Assessment
Jonathan Sockolosky, PhD, personifies the type of researcher that the PhRMA Foundation seeks to support. He sees an important role for himself in the broader ecosystem of drug discovery and development. “It’s important for me to give back to the PhRMA Foundation, both to help continuously fund and inspire the next frontier of scientific innovation, and to ensure that new ideas from early-career researchers have the opportunity to move beyond the idea stage,” he said.
Exploring Career Paths: Community-Based Clinical Research
Are you a medical student or a physician interested in community-based clinical research? The PhRMA Foundation hosted an informational webinar about the Robert A. Winn Diversity in Clinical Trials Award Program, which supports early-stage investigator physicians and medical students of diverse backgrounds interested in becoming community-oriented clinical trialists.
Read the 2021 Annual Report
The PhRMA Foundation is dedicated to funding innovative research and growing a diverse talent pipeline for academia, government, and industry by catalyzing the careers of promising researchers. Learn about our grants and award recipients in our Annual Report.
Learn More About PhRMA Foundation Funding Opportunities
The PhRMA Foundation offers a wide variety of research grants, in categories ranging from predoctoral to postdoctoral and spanning several scientific disciplines. Check our awards page to learn more.